Cass review urges ‘extreme caution’ in prescribing puberty blockers to trans youth
Cass review urges ‘extreme caution’ in prescribing puberty blockers to trans youth
The Cass review into trans youth healthcare has urged 'extreme caution' over prescribing puberty blockers, among other recommendations.
Personally I'd recommend extreme caution in all medical matters
Prescribing the puberty blockers (i.e., delaying the issue) is the extreme cautious option.
This is the claim from the Guardian article about this:
Puberty blockers and hormone treatment had been given to young patients despite a lack of research into their impact
Frankly I find that hard to swallow, given that puberty blockers existed long before they were used to treat trans people. Puberty blockers were used to treat children with extremely early puberty, their effects are generally well known. Sure, there's always the classic "more study is needed" line in academia, but this almost presents it as careless implementation of a new drug, rather than a known and approved drug given to more people.
-
Don't do the research
-
Insist that the lack of research necessitates extreme caution, or even a ban
-
????
-
Protect...women?
-
Here is another news report on it. With less spin.
https://www.independent.co.uk/news/health/cass-review-gender-identity-nhs-b2525787.html
Every article has spin tbf. Neutrality is not a thing that exists.